Q3 2025 QuidelOrtho Corp Earnings Call Transcript
Key Points
- QuidelOrtho Corp (QDEL) reported a 5% organic sales growth, excluding COVID sales and the US donor screening business.
- Adjusted EBITDA expanded to 25% of sales, driven by margin improvement initiatives.
- The company achieved significant cost savings of over $140 million, contributing to sustainable mid to high 20s EBITDA margins.
- Strong performance in international markets, with Latin America growing 21% and Japan, Asia Pacific, and China each growing approximately 5%.
- Successful launch of the new Vitros high sensitivity troponin assay, enhancing the cardiac panel's performance.
- Total reported revenue for Q3 2025 decreased by 4% year over year, primarily due to lower COVID and donor screening revenue.
- Respiratory revenue declined significantly due to a 63% drop in COVID revenue.
- North America revenue was down 12% in total, impacted by the decline in respiratory revenue and the US donor screening exit.
- Adjusted free cash flow was negative $50 million, affected by timing issues related to accounts receivable collections and accounts payable disbursements.
- A $701 million goodwill impairment charge was recorded in Q3, with no goodwill remaining on the balance sheet.
Welcome to the Quedell ortho 3rd quarter, 2025 financial results conference call and webcast.
At this time, all participant lines are in a listen-only mode.
For those of you participating in the conference call, there will be an opportunity for your questions at the end of today's prepared remarks.
Please note this conference call is being recorded.
An audio replay of the conference call will be available on the company's website shortly after this call.
I would now like to turn the call over to Juliet Cunningham, Vice President of Investor Relations.
Thank you.
Good afternoon, everyone.
Thanks for joining the Quel 3rd quarter 2025 Financial results conference call.
Joining me today are Brian Blazer, President and Chief Executive Officer, and Joe Busy, Chief Financial Officer.
This conference call is being simultaneously webcast on the investor relations page of our website.
To assist in the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
